Source: Journal of Clinical Pharmacy and Therapeutics. Unidades: FCFRP, FMRP
Subjects: ANTIVIRAIS, INTERAÇÃO DE MEDICAMENTOS, HEPATITE C, HEPATITE CRÔNICA, GLICOPROTEÍNAS DA MEMBRANA, ANTILIPÊMICOS
ABNT
PIPPA, Leandro Francisco et al. Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis. Journal of Clinical Pharmacy and Therapeutics, v. 114, n. 1, p. 173-181, 2023Tradução . . Disponível em: https://doi.org/10.1002/cpt.2908. Acesso em: 08 out. 2025.APA
Pippa, L. F., Vieira, C. P., Caris, J. A., Rocha, A., Marques, M. P., Garcia, C. P., et al. (2023). Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis. Journal of Clinical Pharmacy and Therapeutics, 114( 1), 173-181. doi:10.1002/cpt.2908NLM
Pippa LF, Vieira CP, Caris JA, Rocha A, Marques MP, Garcia CP, Rezende REF, Lanchote VL. Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2023 ; 114( 1): 173-181.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/cpt.2908Vancouver
Pippa LF, Vieira CP, Caris JA, Rocha A, Marques MP, Garcia CP, Rezende REF, Lanchote VL. Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2023 ; 114( 1): 173-181.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/cpt.2908